The Biobased and Renewable Products Advocacy Group (BRAG) helps members develop and bring to market their innovative biobased and renewable chemical products through insightful policy and regulatory advocacy. BRAG is managed by B&C® Consortia Management, L.L.C., an affiliate of Bergeson & Campbell, P.C.
House Passes Pandemic And All-Hazards Preparedness And Advancing Innovation Act of 2018
  • Email This
  • Print
  • Share Link

By Lynn L. Bergeson

On September 25, 2018, the U.S. House of Representatives passed without objection the Pandemic and All-Hazards Preparedness And Advancing Innovation Act of 2018. Introduced on July 16, 2018, by Congresswoman Susan W. Brooks (R-IN), this Act reauthorizes certain programs under the Pandemic and All-Hazards Preparedness Reauthorization Act, and amends the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act. Amongst these reauthorized programs are the federal biodefense programs and agencies which include the Biomedical Advanced Research and Development Authority, as well as the BioShield Special Reserve Fund, which impact the biotechnology industry. Industry stakeholders positively responded to the passing of this Act, including the Biotechnology Innovation Organization (BIO), a member of the Biobased and Renewable Products Advocacy Group (BRAG®), who congratulated the House in a released statement.